Literature DB >> 3469153

Comparative in vitro antibacterial activity of ofloxacin and ciprofloxacin against some selected gram-positive and gram-negative isolates.

P Y Chau, Y K Leung, W W Ng.   

Abstract

The in vitro activities of ofloxacin and ciprofloxacin were tested against five selected groups of clinical bacterial isolates. Both were active against: Staphylococcus aureus and Staphylococcus epidermidis, irrespective of their resistance to methicillin or gentamicin; Haemophilus influenzae and Neisseria gonorrhoeae, irrespective of their beta-lactamase production; members of the Enterobacteriaceae family which were resistant to most oral beta-lactams, and most intestinal bacterial pathogens including Campylobacter, Vibrio, Salmonella, Shigella and Yersinia. Ciprofloxacin was found more active than ofloxacin against Pseudomonas with most isolates of Pseudomonas aeruginosa and Pseudomonas fluorescens susceptible, while those of Pseudomonas cepacia were resistant.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3469153     DOI: 10.1007/BF01661280

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  4 in total

1.  Pharmacokinetics and tissue penetration of ciprofloxacin.

Authors:  B Crump; R Wise; J Dent
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

2.  In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.

Authors:  G M Eliopoulos; A Gardella; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

3.  In vitro and in vivo activity of DL-8280, a new oxazine derivative.

Authors:  K Sato; Y Matsuura; M Inoue; T Une; Y Osada; H Ogawa; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

4.  Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors:  C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

  4 in total
  4 in total

1.  Comparison of ofloxacin, gentamicin, and tobramycin concentrations in tears and in vitro MICs for 90% of test organisms.

Authors:  J Richman; H Zolezio; D Tang-Liu
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

Review 2.  Ofloxacin clinical pharmacokinetics.

Authors:  K C Lamp; E M Bailey; M J Rybak
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

Review 3.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

4.  Topical ofloxacin compared with gentamicin in the treatment of external ocular infection. Ofloxacin Study Group.

Authors:  A Gwon
Journal:  Br J Ophthalmol       Date:  1992-12       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.